person
as of 2026-07-01Dengtang Liu, MD
Dengtang Liu
at a glance
Roles: Principal Investigator, Study Chair, Study Director, Author
KOL signal score 12
2 publications · 2 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Chief Psychiatrist and Professor
Roles
Principal Investigator, Study Chair, Study Director, Author
KOL signal
12
Publications
2 (2 high-value)
Trial investigator
yes
Publishes on
1 drugs
Trials led
4
Hippocampus DBS in Treatment-resistant Schizophrenia
NCT05694000—Unknown
Study of Repetitive Transcranial Magnetic Stimulation in the Treatment of Cognitive Impairment in Schizophrenia
NCT01940939—Completed
SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia
NCT04528095Phase 3Unknown
Publications & congress
2
Clozapine After 1 Failed Antipsychotic Drug Trial in First-Episode Psychosis: A Randomized Clinical Trial.
JAMA psychiatry · 2026 · high-value
Identification of serum metabolic traits of AIWG in first-episode schizophrenia patients.
BMC psychiatry · 2024 · high-value
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
drug
PRINCIPAL_INVESTIGATOR
STUDY_DIRECTOR